Bioventus Inc. (BVS)
| Previous close | 3.9600 |
| Open | 3.9600 |
| Bid | 3.9000 x 300 |
| Ask | 4.0500 x 300 |
| Day's range | 3.9600 - 4.0200 |
| 52-week range | 0.8600 - 6.0800 |
| Volume | |
| Avg. volume | 142,375 |
| Market cap | 252.881M |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5400 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.00 |
GlobeNewswireBioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-8
Insider MonkeyBioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript March 12, 2024 Bioventus Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this […]
